The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Molecular Testing for Respiratory Pathogens Market Research Report 2025

Global Molecular Testing for Respiratory Pathogens Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1903082

No of Pages : 103

Ask Your Query
Synopsis
Molecular testing for respiratory pathogens involves the use of molecular biology techniques to detect and identify viruses and bacteria causing respiratory infections. Utilizing nucleic acid amplification methods such as polymerase chain reaction (PCR), these tests target specific genetic material unique to pathogens, allowing for sensitive and rapid identification. Molecular assays enable simultaneous detection of multiple respiratory pathogens in a single test, providing comprehensive results for viruses like influenza, respiratory syncytial virus (RSV), and various strains of coronaviruses. These tests play a crucial role in diagnosing respiratory infections accurately, aiding in patient management, infection control, and public health surveillance.
The global Molecular Testing for Respiratory Pathogens market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market for molecular diagnostics in infectious diseases is characterized by rapid technological advancements and a growing emphasis on accurate and timely disease detection. Molecular diagnostics involve the identification of pathogens at the molecular level, enabling quicker and more precise diagnosis of infectious diseases. Factors such as the increasing incidence of infectious diseases, demand for point-of-care testing, and advancements in genomics contribute to the market's expansion. Key players in the industry focus on developing innovative diagnostic platforms and expanding their product portfolios to meet the rising demand for molecular diagnostic solutions. The market is anticipated to experience continuous growth as molecular diagnostics become integral in managing infectious diseases globally, offering benefits such as early detection, personalized treatment strategies, and monitoring of treatment effectiveness.
This report aims to provide a comprehensive presentation of the global market for Molecular Testing for Respiratory Pathogens, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Testing for Respiratory Pathogens.
Report Scope
The Molecular Testing for Respiratory Pathogens market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Molecular Testing for Respiratory Pathogens market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Testing for Respiratory Pathogens manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BioFire Diagnostics
DiaSorin
Seegene
Qiagen
Hoffmann-La Roche
Cepheid (Danaher)
Abbott Laboratories
QuidelOrtho
Illumina
ZeptoMetrix
Sansure
BGI Genomics
bioMérieux
AusDiagnostics
Anatolia Geneworks
DaAn Gene
Segment by Type
Single Pathogen Test
Multiple Pathogen Test
Segment by Application
Hospital
Diagnostic Laboratories
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Molecular Testing for Respiratory Pathogens manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Molecular Testing for Respiratory Pathogens in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Molecular Testing for Respiratory Pathogens Market Overview
1.1 Product Overview and Scope of Molecular Testing for Respiratory Pathogens
1.2 Molecular Testing for Respiratory Pathogens Segment by Type
1.2.1 Global Molecular Testing for Respiratory Pathogens Market Value Comparison by Type (2024-2030)
1.2.2 Single Pathogen Test
1.2.3 Multiple Pathogen Test
1.3 Molecular Testing for Respiratory Pathogens Segment by Application
1.3.1 Global Molecular Testing for Respiratory Pathogens Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Diagnostic Laboratories
1.4 Global Molecular Testing for Respiratory Pathogens Market Size Estimates and Forecasts
1.4.1 Global Molecular Testing for Respiratory Pathogens Revenue 2019-2030
1.4.2 Global Molecular Testing for Respiratory Pathogens Sales 2019-2030
1.4.3 Global Molecular Testing for Respiratory Pathogens Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Molecular Testing for Respiratory Pathogens Market Competition by Manufacturers
2.1 Global Molecular Testing for Respiratory Pathogens Sales Market Share by Manufacturers (2019-2024)
2.2 Global Molecular Testing for Respiratory Pathogens Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Molecular Testing for Respiratory Pathogens Average Price by Manufacturers (2019-2024)
2.4 Global Molecular Testing for Respiratory Pathogens Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Molecular Testing for Respiratory Pathogens, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Molecular Testing for Respiratory Pathogens, Product Type & Application
2.7 Molecular Testing for Respiratory Pathogens Market Competitive Situation and Trends
2.7.1 Molecular Testing for Respiratory Pathogens Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Molecular Testing for Respiratory Pathogens Players Market Share by Revenue
2.7.3 Global Molecular Testing for Respiratory Pathogens Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Molecular Testing for Respiratory Pathogens Retrospective Market Scenario by Region
3.1 Global Molecular Testing for Respiratory Pathogens Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Molecular Testing for Respiratory Pathogens Global Molecular Testing for Respiratory Pathogens Sales by Region: 2019-2030
3.2.1 Global Molecular Testing for Respiratory Pathogens Sales by Region: 2019-2024
3.2.2 Global Molecular Testing for Respiratory Pathogens Sales by Region: 2025-2030
3.3 Global Molecular Testing for Respiratory Pathogens Global Molecular Testing for Respiratory Pathogens Revenue by Region: 2019-2030
3.3.1 Global Molecular Testing for Respiratory Pathogens Revenue by Region: 2019-2024
3.3.2 Global Molecular Testing for Respiratory Pathogens Revenue by Region: 2025-2030
3.4 North America Molecular Testing for Respiratory Pathogens Market Facts & Figures by Country
3.4.1 North America Molecular Testing for Respiratory Pathogens Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Molecular Testing for Respiratory Pathogens Sales by Country (2019-2030)
3.4.3 North America Molecular Testing for Respiratory Pathogens Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Molecular Testing for Respiratory Pathogens Market Facts & Figures by Country
3.5.1 Europe Molecular Testing for Respiratory Pathogens Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Molecular Testing for Respiratory Pathogens Sales by Country (2019-2030)
3.5.3 Europe Molecular Testing for Respiratory Pathogens Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Molecular Testing for Respiratory Pathogens Market Facts & Figures by Country
3.6.1 Asia Pacific Molecular Testing for Respiratory Pathogens Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Molecular Testing for Respiratory Pathogens Sales by Country (2019-2030)
3.6.3 Asia Pacific Molecular Testing for Respiratory Pathogens Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Molecular Testing for Respiratory Pathogens Market Facts & Figures by Country
3.7.1 Latin America Molecular Testing for Respiratory Pathogens Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Molecular Testing for Respiratory Pathogens Sales by Country (2019-2030)
3.7.3 Latin America Molecular Testing for Respiratory Pathogens Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Molecular Testing for Respiratory Pathogens Market Facts & Figures by Country
3.8.1 Middle East and Africa Molecular Testing for Respiratory Pathogens Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Molecular Testing for Respiratory Pathogens Sales by Country (2019-2030)
3.8.3 Middle East and Africa Molecular Testing for Respiratory Pathogens Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Molecular Testing for Respiratory Pathogens Sales by Type (2019-2030)
4.1.1 Global Molecular Testing for Respiratory Pathogens Sales by Type (2019-2024)
4.1.2 Global Molecular Testing for Respiratory Pathogens Sales by Type (2025-2030)
4.1.3 Global Molecular Testing for Respiratory Pathogens Sales Market Share by Type (2019-2030)
4.2 Global Molecular Testing for Respiratory Pathogens Revenue by Type (2019-2030)
4.2.1 Global Molecular Testing for Respiratory Pathogens Revenue by Type (2019-2024)
4.2.2 Global Molecular Testing for Respiratory Pathogens Revenue by Type (2025-2030)
4.2.3 Global Molecular Testing for Respiratory Pathogens Revenue Market Share by Type (2019-2030)
4.3 Global Molecular Testing for Respiratory Pathogens Price by Type (2019-2030)
5 Segment by Application
5.1 Global Molecular Testing for Respiratory Pathogens Sales by Application (2019-2030)
5.1.1 Global Molecular Testing for Respiratory Pathogens Sales by Application (2019-2024)
5.1.2 Global Molecular Testing for Respiratory Pathogens Sales by Application (2025-2030)
5.1.3 Global Molecular Testing for Respiratory Pathogens Sales Market Share by Application (2019-2030)
5.2 Global Molecular Testing for Respiratory Pathogens Revenue by Application (2019-2030)
5.2.1 Global Molecular Testing for Respiratory Pathogens Revenue by Application (2019-2024)
5.2.2 Global Molecular Testing for Respiratory Pathogens Revenue by Application (2025-2030)
5.2.3 Global Molecular Testing for Respiratory Pathogens Revenue Market Share by Application (2019-2030)
5.3 Global Molecular Testing for Respiratory Pathogens Price by Application (2019-2030)
6 Key Companies Profiled
6.1 BioFire Diagnostics
6.1.1 BioFire Diagnostics Corporation Information
6.1.2 BioFire Diagnostics Description and Business Overview
6.1.3 BioFire Diagnostics Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2019-2024)
6.1.4 BioFire Diagnostics Molecular Testing for Respiratory Pathogens Product Portfolio
6.1.5 BioFire Diagnostics Recent Developments/Updates
6.2 DiaSorin
6.2.1 DiaSorin Corporation Information
6.2.2 DiaSorin Description and Business Overview
6.2.3 DiaSorin Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2019-2024)
6.2.4 DiaSorin Molecular Testing for Respiratory Pathogens Product Portfolio
6.2.5 DiaSorin Recent Developments/Updates
6.3 Seegene
6.3.1 Seegene Corporation Information
6.3.2 Seegene Description and Business Overview
6.3.3 Seegene Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Seegene Molecular Testing for Respiratory Pathogens Product Portfolio
6.3.5 Seegene Recent Developments/Updates
6.4 Qiagen
6.4.1 Qiagen Corporation Information
6.4.2 Qiagen Description and Business Overview
6.4.3 Qiagen Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Qiagen Molecular Testing for Respiratory Pathogens Product Portfolio
6.4.5 Qiagen Recent Developments/Updates
6.5 Hoffmann-La Roche
6.5.1 Hoffmann-La Roche Corporation Information
6.5.2 Hoffmann-La Roche Description and Business Overview
6.5.3 Hoffmann-La Roche Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hoffmann-La Roche Molecular Testing for Respiratory Pathogens Product Portfolio
6.5.5 Hoffmann-La Roche Recent Developments/Updates
6.6 Cepheid (Danaher)
6.6.1 Cepheid (Danaher) Corporation Information
6.6.2 Cepheid (Danaher) Description and Business Overview
6.6.3 Cepheid (Danaher) Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cepheid (Danaher) Molecular Testing for Respiratory Pathogens Product Portfolio
6.6.5 Cepheid (Danaher) Recent Developments/Updates
6.7 Abbott Laboratories
6.6.1 Abbott Laboratories Corporation Information
6.6.2 Abbott Laboratories Description and Business Overview
6.6.3 Abbott Laboratories Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abbott Laboratories Molecular Testing for Respiratory Pathogens Product Portfolio
6.7.5 Abbott Laboratories Recent Developments/Updates
6.8 QuidelOrtho
6.8.1 QuidelOrtho Corporation Information
6.8.2 QuidelOrtho Description and Business Overview
6.8.3 QuidelOrtho Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2019-2024)
6.8.4 QuidelOrtho Molecular Testing for Respiratory Pathogens Product Portfolio
6.8.5 QuidelOrtho Recent Developments/Updates
6.9 Illumina
6.9.1 Illumina Corporation Information
6.9.2 Illumina Description and Business Overview
6.9.3 Illumina Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Illumina Molecular Testing for Respiratory Pathogens Product Portfolio
6.9.5 Illumina Recent Developments/Updates
6.10 ZeptoMetrix
6.10.1 ZeptoMetrix Corporation Information
6.10.2 ZeptoMetrix Description and Business Overview
6.10.3 ZeptoMetrix Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2019-2024)
6.10.4 ZeptoMetrix Molecular Testing for Respiratory Pathogens Product Portfolio
6.10.5 ZeptoMetrix Recent Developments/Updates
6.11 Sansure
6.11.1 Sansure Corporation Information
6.11.2 Sansure Molecular Testing for Respiratory Pathogens Description and Business Overview
6.11.3 Sansure Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sansure Molecular Testing for Respiratory Pathogens Product Portfolio
6.11.5 Sansure Recent Developments/Updates
6.12 BGI Genomics
6.12.1 BGI Genomics Corporation Information
6.12.2 BGI Genomics Molecular Testing for Respiratory Pathogens Description and Business Overview
6.12.3 BGI Genomics Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2019-2024)
6.12.4 BGI Genomics Molecular Testing for Respiratory Pathogens Product Portfolio
6.12.5 BGI Genomics Recent Developments/Updates
6.13 bioMérieux
6.13.1 bioMérieux Corporation Information
6.13.2 bioMérieux Molecular Testing for Respiratory Pathogens Description and Business Overview
6.13.3 bioMérieux Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2019-2024)
6.13.4 bioMérieux Molecular Testing for Respiratory Pathogens Product Portfolio
6.13.5 bioMérieux Recent Developments/Updates
6.14 AusDiagnostics
6.14.1 AusDiagnostics Corporation Information
6.14.2 AusDiagnostics Molecular Testing for Respiratory Pathogens Description and Business Overview
6.14.3 AusDiagnostics Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2019-2024)
6.14.4 AusDiagnostics Molecular Testing for Respiratory Pathogens Product Portfolio
6.14.5 AusDiagnostics Recent Developments/Updates
6.15 Anatolia Geneworks
6.15.1 Anatolia Geneworks Corporation Information
6.15.2 Anatolia Geneworks Molecular Testing for Respiratory Pathogens Description and Business Overview
6.15.3 Anatolia Geneworks Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Anatolia Geneworks Molecular Testing for Respiratory Pathogens Product Portfolio
6.15.5 Anatolia Geneworks Recent Developments/Updates
6.16 DaAn Gene
6.16.1 DaAn Gene Corporation Information
6.16.2 DaAn Gene Molecular Testing for Respiratory Pathogens Description and Business Overview
6.16.3 DaAn Gene Molecular Testing for Respiratory Pathogens Sales, Revenue and Gross Margin (2019-2024)
6.16.4 DaAn Gene Molecular Testing for Respiratory Pathogens Product Portfolio
6.16.5 DaAn Gene Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Molecular Testing for Respiratory Pathogens Industry Chain Analysis
7.2 Molecular Testing for Respiratory Pathogens Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Molecular Testing for Respiratory Pathogens Production Mode & Process
7.4 Molecular Testing for Respiratory Pathogens Sales and Marketing
7.4.1 Molecular Testing for Respiratory Pathogens Sales Channels
7.4.2 Molecular Testing for Respiratory Pathogens Distributors
7.5 Molecular Testing for Respiratory Pathogens Customers
8 Molecular Testing for Respiratory Pathogens Market Dynamics
8.1 Molecular Testing for Respiratory Pathogens Industry Trends
8.2 Molecular Testing for Respiratory Pathogens Market Drivers
8.3 Molecular Testing for Respiratory Pathogens Market Challenges
8.4 Molecular Testing for Respiratory Pathogens Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock